Validation of a New Risk Assessment Model for Predicting Adverse Events in Children With Fever and Chemotherapy-Induced Neutropenia
Karin G. E. Miedema(University Medical Center Groningen), Wim J. E. Tissing(University Medical Center Groningen), Claudi S. M. Oude Nijhuis(University Medical Center Groningen), Danique van Vliet(University Medical Center Groningen), Eveline S.J.M. de Bont(Hôpital Saint-Michel), Willem A. Kamps(Pediatric Oncology Group)
Cited by 33
Related Papers
Prognostic value of minimal residual disease in acute lymphoblastic leukaemia in childhood
|The Lancet|1998|964
A subtype of childhood acute lymphoblastic leukaemia with poor treatment outcome: a genome-wide classification study
|The Lancet Oncology|2009|932
Evidence Based Selection of Housekeeping Genes
|PLoS ONE|2007|772
Outcome of Treatment in Children with Philadelphia Chromosome–Positive Acute Lymphoblastic Leukemia
|New England Journal of Medicine|2000|599